Top 5 Most-Read AJMC® Journal Articles of 2022

In 2022, the articles published in the peer-reviewed The American Journal of Managed Care^® (AJMC^®) explored care management interventions, savings from biosimilars, and much more.

Here are the 5 most-read AJMC^® journal articles in 2022.

5. Intensive Care Management of a Complex Medicaid Population: A Randomized Evaluation

In this original research article published in the September issue, the authors detail findings from a randomized evaluation of a program that delivered intensive care management to a high-cost, high-need population enrolled in Medicare. They find that patients receiving care management had a smaller increase in per-member per-month total medical expenditures compared with controls, as well as a non–statistically significant reduction in utilization.

Read the full article.

4. Characteristics of Home-Based Care Provided by Accountable Care Organizations

This Trends from the Field article published in the May issue reports survey findings describing how accountable care organizations (ACOs) use home-based care programs, such as for primary care, acute care, palliative care, or care transitions. Although the ACOs reported delivering a diverse array of home-visit services, many ACO leaders were hesitant to expand these services due to uncertain return on investment. The authors suggest covering telehealth for patients receiving home-based primary care to address some of the concerns surrounding financial viability.

Read the full article.

3. Projected US Savings From Biosimilars, 2021-2025

In this original research article, published in the July issue but appearing online early in January, researchers estimate new savings from biosimilar competition in 2021 through 2025 compared with the 2020 baseline across scenarios with varying price competition and biosimilar uptake. Their main analysis yielded a savings estimate of $38.4 billion, most of which will result from downward pressure on reference biologic prices. The authors note that “greater savings may be feasible if managed care and other settings increase biosimilar utilization and promote competition.”

Read the full article.

2. Predictors of Discharge From the VA Caregiver Support Program

This original research article published in the August issue describes trends in discharges from a Department of Veterans Affairs (VA) program that provides training and a stipend to caregivers of veterans with service-related injuries. They find that nonspouse caregivers had the highest rates of discharge, and in some networks, caregivers of Black veterans were more likely to be discharge. The investigators call for greater training within the VA around appropriate criteria for discharge from the program.

Read the full article.

1. FDA Safety Warnings and Trends in Testosterone Marketing to Physicians

This letter published in the March issue evaluates trends in testosterone marketing practices around the time of a safety warning from the FDA and find that marketing efforts for the drug did increase among urban physicians and non–primary care physicians for 4 quarters after the boxed warning. “Understanding responses of pharmaceutical companies to FDA guidelines is important and can help inform future guideline initiatives,” the authors wrote.

Read the full article.